Study on the complications by chronic diabetes mellitus type II in Quetta Balochistan
DOI:
https://doi.org/10.31580/pjmls.v2i3.1126Keywords:
Complications, neeuropathy, nephropathy, CVD, QuettaAbstract
Due to worl wide increase in Diabetes Mellitus, a rise community consciousness about influence of hyperglycemiea and its most common complications ike stroke, hypertension, nephropathy, amputation, neuropathy, cardiovascular and retinopathy etc is required. Awareness on adoption of good diet, physical activities as well as a healthy life-style is required for a healthy long life . Therefore, this study has been designed to investigate the burden of complications of chronic diabetes mellitus in diabetic patients of Quetta city, in order to improve the health status and life style of diabetic patients living in Quetta. Details of all the complications caused by diabetes mellitus were collected from the patients and the bllood glucose was permormed by standard method. This study reaveled the frequency percentage of comorbidities in this order crdiovascular conditions 30% > neuropathy conditions 17.8% > Ocular conditions 14.8% > Nephropathy conditions 10.7% > Cerebrovascular 6.8% > Feet conditions 1.5% > Amputations 0.1%. These results are in agreement to previous studies which showed the highest prevelance of cardiovascular diseases (CVDs) in diabetic patients with hyperglycemia, hypertension, smoking habits and unhealthy life styles.
References
2. Hwee W. Health-related Quality of Life in People with Diabetes Mellitus: Perspective from a Multiethnic Asian Population, PhD Thesis. 2005.
3. IDF. International Diabetes Federation. 2015.
4. Bhandari GP, Angdembe MR, Dhimal M, Neupane S, Bhusal C. State of non-communicable diseases in Nepal. BMC public health. 2014 Dec;14(1):23.
5. Mailloux, Lionel. "Dialysis in diabetic nephropathy".2007.
6. Yau JW, Rogers SL, Kawasaki R, Lamoureux, EL, Kowalski JW, Bek T, ... & Haffner, S.. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care. 2012 35(3), 556-564.
7. Naheed T, Khan A, Masood G, Yunus BB, Chaudry MA. Dyslipidemias in type II diabetes mellitus patients in a teaching hospital of Lahore, Pakistan. Pakistan Journal of Medical Sciences. 2003;19(4):283-6.
8. Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Experimental & Clinical Cardiology. 2007;12(1):17.
9. Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes care. 2011 May 1;34(5):1228-37.
10. Wu L, and Parhofer KG. "Diabetic dyslipidemia." Metabolism-Clinical and Experimental. 2014, 63(12): 1469-1479.
11. Nathan DM, Cleary PA, Backlund JY, et. al. "Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes". The New England Journal of Medicine. 2005. 353 (25): 2643–53.
12. Organization, WH. "Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia”: report of a WHO/IDF consultation. 2006.
13. Vazquez-Benitez G, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Butler MG, Karter AJ, Steiner JF, Newton KM. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015 May 1;38(5):905-12.
